PL211028A1 - Sposob wytwarzania antybiotyku c-15003 p-3 - Google Patents

Sposob wytwarzania antybiotyku c-15003 p-3

Info

Publication number
PL211028A1
PL211028A1 PL21102878A PL21102878A PL211028A1 PL 211028 A1 PL211028 A1 PL 211028A1 PL 21102878 A PL21102878 A PL 21102878A PL 21102878 A PL21102878 A PL 21102878A PL 211028 A1 PL211028 A1 PL 211028A1
Authority
PL
Poland
Prior art keywords
antibiotic
production
Prior art date
Application number
PL21102878A
Other languages
English (en)
Other versions
PL122463B1 (en
Inventor
Eiji Higashide
Kazunori Hatano
Mitsuko Asai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PL211028A1 publication Critical patent/PL211028A1/pl
Publication of PL122463B1 publication Critical patent/PL122463B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/872Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL1978211028A 1977-11-18 1978-11-17 Process for preparing novel c-15003 p-3 antibiotic PL122463B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52139385A JPS6016236B2 (ja) 1977-11-18 1977-11-18 抗生物質c―15003 p―3の製造法

Publications (2)

Publication Number Publication Date
PL211028A1 true PL211028A1 (pl) 1979-07-16
PL122463B1 PL122463B1 (en) 1982-07-31

Family

ID=15244070

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978211028A PL122463B1 (en) 1977-11-18 1978-11-17 Process for preparing novel c-15003 p-3 antibiotic

Country Status (13)

Country Link
US (1) US4228239A (pl)
JP (1) JPS6016236B2 (pl)
CH (1) CH640270A5 (pl)
DE (1) DE2849696A1 (pl)
DK (1) DK144657C (pl)
ES (1) ES475178A1 (pl)
FR (1) FR2409307A1 (pl)
GB (1) GB2011385B (pl)
HU (1) HU179600B (pl)
IT (1) IT1206651B (pl)
NL (1) NL7811325A (pl)
PL (1) PL122463B1 (pl)
SU (1) SU1036251A3 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS55162791A (en) * 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) * 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) * 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
US6573074B2 (en) * 2000-04-12 2003-06-03 Smithkline Beecham Plc Methods for ansamitocin production
US20110313230A1 (en) 2001-05-11 2011-12-22 Terrance Grant Johns Specific binding proteins and uses thereof
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
EP1627069A4 (en) * 2002-08-08 2010-06-02 Glaxosmithkline Llc PROCESS FOR THE ISOLATION AND PURIFICATION OF ANSAMITOCINES
US7432088B2 (en) 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
WO2007067698A2 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
US20110076232A1 (en) 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
CN101921817A (zh) * 2010-09-07 2010-12-22 上海交通大学 安莎霉素发酵产量提高方法
DK2836485T3 (en) * 2012-03-17 2018-04-23 Polyphor Ag CONFORMITY LIMITED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3902968A (en) * 1974-04-25 1975-09-02 Merck & Co Inc Fermentation process
JPS58876B2 (ja) * 1975-11-19 1983-01-08 藤沢薬品工業株式会社 Fr −1923 ブツシツノ セイゾウホウホウ
US4151042A (en) * 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6010718B2 (ja) * 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル,メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
FR2385714A1 (fr) * 1977-03-31 1978-10-27 Takeda Chemical Industries Ltd Nouvel antibiotique denomme c-15003, son procede de preparation et son application comme medicament
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia

Also Published As

Publication number Publication date
IT1206651B (it) 1989-04-27
IT7829922A0 (it) 1978-11-17
ES475178A1 (es) 1979-05-16
DE2849696A1 (de) 1979-05-23
DK514378A (da) 1979-05-19
PL122463B1 (en) 1982-07-31
GB2011385A (en) 1979-07-11
CH640270A5 (de) 1983-12-30
JPS6016236B2 (ja) 1985-04-24
SU1036251A3 (ru) 1983-08-15
US4228239A (en) 1980-10-14
FR2409307A1 (fr) 1979-06-15
NL7811325A (nl) 1979-05-22
DK144657C (da) 1982-11-22
DK144657B (da) 1982-05-03
GB2011385B (en) 1982-05-26
HU179600B (en) 1982-11-29
JPS5473194A (en) 1979-06-12
FR2409307B1 (pl) 1981-03-06

Similar Documents

Publication Publication Date Title
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL205498A1 (pl) Sposob wytwarzania pochodnych morfiny
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL211028A1 (pl) Sposob wytwarzania antybiotyku c-15003 p-3
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL205592A1 (pl) Sposob wytwarzania nitrozobenzenu
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL211027A1 (pl) Sposob wytwarzania antybiotyku c-15003-p4
PL208318A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL209049A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL201541A1 (pl) Sposob wytwarzania nowego antybiotyku
PL204212A1 (pl) Sposob wytwarzania pochodnych p-nitrozodwufenylohydroksyloaminy
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL207755A1 (pl) Sposob wytwarzania nowego antybiotyku